Skip to main content
Fig. 3 | BMC Complementary Medicine and Therapies

Fig. 3

From: Network pharmacological analysis of corosolic acid reveals P4HA2 inhibits hepatocellular carcinoma progression

Fig. 3

Bioinformatics analysis of differentially expressed proteins in hepatocellular carcinoma cells after corosolic acid treatment. (A) BP, CC, MF process analysis of 44 potential target proteins of corosolic acid, pathways that overlap with GO terms in liver cancer are shown in red. (B) KEGG analysis of 44 potential target proteins of corosolic acid, the pathways that overlap with the KEGG pathway in liver cancer are shown in blue

Back to article page